TY  - GEN
AU  - Montero, Maria M
AU  - Domene-Ochoa, Sandra
AU  - López-Causapé, Carla
AU  - Luque, Sonia
AU  - Sorli, Luisa
AU  - Campillo, Nuria
AU  - Padilla, Eduardo
AU  - Prim, Nuria
AU  - Ferrer-Alapont, Lorena
AU  - Angulo-Brunet, Ariadna
AU  - Grau, Santiago
AU  - Oliver, Antonio
AU  - Horcajada, Juan P
PY  - 2021
DO  - 10.1038/s41598-021-01784-4
SN  - 2045-2322
UR  - https://hdl.handle.net/20.500.12105/23320
AB  - Ceftolozane/tazobactam (C/T) has emerged as a potential agent for the treatment of extensively drug-resistant (XDR) Pseudomonas aeruginosa infections. As it is a time-dependent antimicrobial, prolonged infusion may help achieve...
LA  - eng
PB  - Nature Publishing Group
KW  - Dose-Response Relationship, Drug
KW  - Drug Resistance, Multiple, Bacterial
KW  - Anti-Bacterial Agents
KW  - In Vitro Techniques
KW  - Microbial Sensitivity Tests
KW  - Humans
KW  - Cephalosporins
KW  - Pseudomonas aeruginosa
KW  - Tazobactam
KW  - Pseudomonas Infections
TI  - Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model
TY  - research article
ER  -